Sign up for Table of Contents Alerts.
Cell Cycle is published 24 times a year.
Email this page
Print this page
Brief Report
E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression
Gustavo Palacios, Flaminia Talos, Alice Nemajerova, Ute M. Moll and Oleksi Petrenko
volume 7 | issue 12
15 June 2008Pages: 1776 - 1781
Subscribe to this journal for $129/year
To better understand the role of E2F1 in tumor formation, we analyzed spontaneous tumorigenesis in p53-/-E2F1+/+ and p53-/-E2F1-/- mice. We show that the combined loss of p53 and E2F1 leads to an increased incidence of sarcomas and carcinomas compared to the loss of p53 alone. E2F1-deficient tumors show wide chromosomal variation, indicative of genomic instability. Consistent with this, p53-/-E2F1-/- primary fibroblasts have a reduced capacity to maintain genomic stability when exposed to S-phase inhibitors or genotoxic drugs. A major mechanism of E2F1s contribution to genomic integrity lies in mediating stabilization and engagement of the Rb protein.
Authors
Gustavo Palacios
State University of New York at Stony Brook; Stony Brook, NY
Flaminia Talos
State University of New York at Stony Brook; Stony Brook, NY
Alice Nemajerova
State University of New York at Stony Brook; Stony Brook, NY
Ute M. Moll
Stony Brook University; Stony Brook, NY
Oleksi Petrenko
State University of New York at Stony Brook; Stony Brook, NY









